Navigation Links
SomaLogic Announces Research Agreement with Leading Global Pharmaceutical Company to Accelerate Pharmaceutical Discovery and Development
Date:10/18/2011

BOULDER, Colo., Oct. 18, 2011 /PRNewswire/ -- SomaLogic, Inc., announced today that it has entered into a multi-year research agreement with Novartis to use its unique proprietary proteomics technology to accelerate Novartis' drug discovery and development efforts.

"We are excited by this opportunity to work with Novartis' world-class researchers to help them define robust biomarkers, validate novel drug targets, and even develop companion clinical diagnostics," said Larry Gold, CEO of SomaLogic. "We believe that our technology is uniquely able to address the significant drug discovery and development challenges currently faced by biopharmaceutical companies."

Terms of the agreement were not disclosed.

SomaLogic's proprietary proteomic platform is built on two decades of painstaking work to develop an entirely new generation of specific protein-binding reagents that would break open protein biomarker discovery and development in order to drive new diagnostic and therapeutic opportunities. At the heart of SomaLogic's technology are "SOMAmers" (Slow-Offrate Modified Aptamers), an entirely novel class of protein-binding reagents. SOMAmers offer a uniquely powerful combination of specific binding to individual proteins and facile nucleic acid-based quantification, allowing accurate detection and measurement of literally thousands of proteins over a vast range of concentrations in just a few drops of blood or other tissues.

About SomaLogic

SomaLogic, Inc., is a privately held biomarker discovery and clinical diagnostics company based in Boulder, Colorado. The company's mission is to use its proprietary Slow Off-rate Modified Aptamer ("SOMAmer") technology to develop enhanced protein analysis tools and reagents for the life sciences community, to facilitate biomarker discovery and validation for diagnostic and therapeutic applications, and to develop and commercialize clinical diagnostic products that will improve the delivery of he
'/>"/>

SOURCE SomaLogic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. NEC and SomaLogic Enter Agreement to Prepare for Delivery of Novel Forms of Health Information via Cloud Services
2. Rock Creek Pharmaceuticals Announces Expanded International Shipping Options for Anatabloc™, Physician Conferences on Anatabine Research
3. Hologic Announces Jury Verdict in Patent Infringement Suit
4. Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
5. Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community
6. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
7. Ampio Pharmaceuticals Announces a Proof of Concept Trial of Danazol in the Treatment of Allergic Rhinitis Supports Mechanism of Action of Optina™
8. Bend Research Announces Schedule of Events at 2011 AAPS Annual Meeting and Exposition
9. Pacira Pharmaceuticals, Inc. Announces Key EXPAREL™ Data to be Presented at American College of Surgeons 97th Annual Clinical Congress
10. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
11. Express Scripts Announces Third Quarter 2011 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Sept. 4, 2015  Luminex Corporation (NASDAQ: LMNX ... Morgan Stanley Global Healthcare Conference to be held September ... in New York City . ... Eastern time on Friday, September 18, 2015.  The presentation ... Corporation,s website at http://www.luminexcorp.com . Simply log on to ...
(Date:9/4/2015)... , Sept. 4, 2015  Cumberland Pharmaceuticals (CPIX), ... will present live at VirtualInvestorConferences.com on September 10, 2015. ... 2:30p.m. ET LINK: http://tinyurl.com/sep10pre ... where investors are invited to ask the company questions ... well as the association,s "virtual trade booth." If attendees ...
(Date:9/4/2015)... , Sep. 04, 2015 ... announced the addition of the "Pharmacovigilance (London, ... their offering. Understanding PhV today - ... those working in Drug safety. This ... concerned with pharmacovigilance. New entrants as well as ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Pharmacovigilance Course: The Principles and Practice of Global PhV for those Working in Drug Safety (London, UK - December 7-9, 2015) 2
... 3, 2012 Radient Pharmaceuticals Corporation (OTCQX:RXPC) (OTCPK:RXPC), a developer ... announced that its Board of Directors has authorized the implementation ... shares, which will be completed on or before January 15, ... to the Board by the Company,s stockholders at a November ...
...   GP Strategies Corporation (NYSE: GPX ... and technical training, e-Learning solutions, management consulting and engineering ... Capital") has agreed to purchase 350,000 shares in a ... of the transaction is subject to customary conditions and ...
Cached Medicine Technology:Radient Pharmaceuticals Announces Reverse Stock Split 2Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P. 2Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P. 3
(Date:9/4/2015)... Angeles, CA (PRWEB) , ... September 04, 2015 , ... ... Program was ranked number 9 nationwide by Doximity. Faculty, residents and staff ... we take great pride in the quality of our ophthalmology residency program. Our faculty ...
(Date:9/4/2015)... ... September 04, 2015 , ... Having access to a doctor ... to an increasing amount of unnecessary emergency room visits which affects hospitals’ abilities to ... country’s health bill. Fortunately, a solution to alleviate this problem has recently presented itself, ...
(Date:9/4/2015)... New York, NY (PRWEB) , ... September 04, 2015 , ... ... 400 meters qualifying heat, and followed up with victory in the men’s 400 meters ... Caribbean (NACAC) Senior Track and Field Championships in San Jose, Costa Rica in August ...
(Date:9/4/2015)... ... 2015 , ... Compliance officers deal with many high-risk issues, ... self-referral law. “Stark Law DOs and DON’Ts: Best Practices for Your Physician ... will detail which deals are attracting the most government scrutiny and what are ...
(Date:9/4/2015)... ... September 04, 2015 , ... FiltersFast.com, the online retail ... cannot be passed up. FiltersFast.com, will ship all orders over $50.00 for ... product replacements. Take advantage of this promotion now through September 8, 2015. , ...
Breaking Medicine News(10 mins):Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2
... a planned light rail line in the Twin Cities would ... the people in the communities it would pass through, according ... TakeAction Minnesota, and ISAIAH, a nonprofit coalition of 90 congregations ... Cloud region. The HIA was made possible through a grant ...
... WEDNESDAY, Jan. 4 (HealthDay News) -- People who lack the ... are more likely to be aggressive when they,re drunk, a ... and now, without thinking about the impact on the future, ... the effect is magnified greatly when they,re drunk," study author ...
... , WEDNESDAY, Jan. 4 (HealthDay News) -- Physicians need ... patients to prevent harmful interactions between drugs, experts ... of Neurology (AAN) has led to the issuance of ... with the International League Against Epilepsy. "It is ...
... 4, 2012 -- ,CHAPEL HILL People with high cholesterol ... plaques within their arteries can rupture triggering the formation of ... the blood supply to their heart or brain. ... clotting. Now, a study led by researchers from the University ...
... , WEDNESDAY, Jan. 4 (HealthDay News) -- Men appear more ... Asians with the neurologic disorder, a large U.S. study reveals. ... from dementia had a higher death rate from Parkinson,s disease. ... patients across the United States who were Medicare beneficiaries between ...
... rotovirus vaccine was pulled from the marketplace in 1999 ... updated rotavirus vaccines do not appear to increase the ... a new study by child health experts at C.S. ... the vaccine,re-introduced in 2006 and 2008, prevent infection by ...
Cached Medicine News:Health News:Twin Cities light rail project presents both opportunities and risks for health, according to report 2Health News:Twin Cities light rail project presents both opportunities and risks for health, according to report 3Health News:Study Reveals Who's More Prone to Be a 'Mean Drunk' 2Health News:New Guidelines Issued for Combining HIV, Seizure Meds 2Health News:Benefits of statin therapy may extend beyond lowering lipids 2Health News:Race, Gender, Dementia May Affect Parkinson's Survival 2Health News:U-M study shows updated rotavirus vaccine not linked to increase in bowel obstruction 2
... Agarose 3:1 HRB™ (High Resolution Blend), is ... provide high resolution of small nucleic acids ... of DNA fragmanets less than 1,000 bp. ... without smearing of high background fluorescence. The ...
... is specifically formulated for high resolution of ... bp. This standard melting temperature agarose can ... 10 bp difference in size. UltraPure™ ... structure for better handling and improved clarity ...
... low electroendosmosis (EEO) is ... applications. If separated nucleic ... used as substrates for ... restriction endonucleases, a special ...
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
Medicine Products: